About Klox Technologies Inc.
Klox Technologies Inc. is a private biomedical technology innovator, advancing the development and commercialization of its flagship fluorescence generating technology for specific skin/soft tissue conditions and diseases. With franchises in wound care, dermatology, veterinary and oral health, Klox is well positioned to capitalize on significant market opportunities. We believe that our dedication to providing healthcare professionals with novel and effective treatment solutions will allow patients to experience positive results without some of the side effects associated with existing treatments such as antibiotic resistance.
Klox Technologies’ management team works seamlessly in all phases of business Commercialization, Development and Partnership, delivering results in the biotechnology, pharmaceutical and medical device industries. We continue to advance solutions based on our fluorescence biomodulation technology for a growing and aging population that is seeking more effective and less invasive treatment options to improve their health and quality of life.
What is our corporate mission?
Klox strives to maximize and expand the benefits of fluorescence biomodulation. One of the key drivers in our development process is to identify treatment ‘gaps’ and unmet needs in skin/soft-tissue related conditions and disease states. We then explore new applications and treatment benefits for these conditions in humans and in animals.
We want to take fluorescence biomodulation technology to a new level. Across all our core disease categories, every product that we have introduced provides a superior benefit compared to current standard approaches.